# 17OHP-C Dosing Among Obese Pregnant Women

> **NCT03433040** · PHASE3 · COMPLETED · sponsor: **University of South Florida** · enrollment: 44 (actual)

## Conditions studied

- Premature Birth
- Absorption; Chemicals

## Interventions

- **DRUG:** 17-Hydroxyprogesterone Capronate

## Key facts

- **NCT ID:** NCT03433040
- **Lead sponsor:** University of South Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-23
- **Primary completion:** 2021-06-01
- **Final completion:** 2021-07-14
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03433040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03433040, "17OHP-C Dosing Among Obese Pregnant Women". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03433040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*